The Corporate Press Release Ledger tracks 8-K Regulation FD and Item 7.01 and 8.01 press-release filings with extracted exhibit titles, detected wire services and topic families, drawn from public SEC EDGAR data over a rolling window and refreshed daily. Every entry links the official filing; topics are derived labels, not issuer claims.
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval